Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 624-626

  Amoli, Mahsa M ^a,b   Lopez Agreda, Hugo ^c   Suarez Amor, Oscar ^c   Martin, Javier ^d   Oilier, William E R ^a   Gonzalez Gay, Miguel A ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HOSPITAL XERAL CALDE   (Spain)

^d INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Disease susceptibility; eNOS polymorphism; Erythema nodosum; Genetic association; Sarcoidosis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHEMA NODOSUM; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SARCOIDOSIS; SKIN BIOPSY; TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; ERYTHEMA NODOSUM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; SARCOIDOSIS; TANDEM REPEAT SEQUENCES;

EID: 34648831275     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GONZALEZ-GAY MA, GARCIA-PORRUA C, PUJOL RM, SALVARANI C: Erythema nodosum: A clinical approach. Clin Exp Rheumatol 2001; 19: 365-8.
2. ATZENI F, CARRABBA M, DAVIN JC et al.: Skin manifestations in vasculitis and erythema nodosum. Clin Exp Rheumatol 2006; 24 (Suppl. 40): S60-6.
3. CLANCY RM, AMIN AR, ABRAMSON SB: The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998; 41: 1141-51.
4. WEINBERG JB: Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagoeytes: A review. Mol Med 1998; 4: 557-91.
5. SALVARANI C, CASALI B, NICOLI D et al.: Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 2003; 48: 3219-23.
6. AMOLI MM, GARCIA-PORRUA C, LLORCA J, OLLIER WE, GONZALEZ-GAY MA: Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol 2003; 30: 2019-22.
7. SALVARANI C, BOIARDI L, CASALI B et al.: Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 2002; 29: 535-40.
8. AMOLI MM, DONN RA, THOMSON W et al.: Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy-proven erythema nodosum: J Rheumatol 2002; 29: 1671-3.
9. AMOLI MM, LLORCA J, GOMEZ-GIGIREY A et al.: E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Cin Exp Rheumatol 2004; 22: 230-2.
10. GARCIA-PORRUA C, GONZALEZ-GAY MA, VAZQUEZ-CARUNCHO M et al.: Erythema nodosum: Etiologic and predictive factors in a defined population. Arthritis Rheum 2000; 43: 584-92.
11. AMOLI MM, THOMSON W, HAJEER AH et al.: FILA-DRB1 associations in biopsy-proven erythema nodosum. J Rheumatol 2001; 28: 2660-2.
12. GONZALEZ-GAY MA, GARCIA-PORRUA C, HAJEER AH: The HLA-DRB1 influence in the susceptibility and severity to rheumatoid arthritis. Semin Arthritis Rheum 2002; 31: 355-60.
13. GONZALEZ-GAY MA, ALONSO MD, AGUERO JJ, BAL M, FERNANDEZ-CAMBLOR B, SANCHEZ-ANDRADE A: Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 1992; 19: 277-80.
14. GONZALEZ-GAY MA, GARCIA-PORRUA C, GUERRERO J, RODRIGUEZ-LEDO P, LLORCA J: The epidemiology of the primary systemic vasculitides in northwest Spain: Implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003; 49: 388-93.
15. AMOLI MM, GARCIA-PORRUA C, CALVINO MC, OLLIER WE, GONZALEZ-GAY MA: Lack of association between endothelial nitric oxide synthase polymorphisms and Henoch-Schonlein purpura. J Rheumatol 2004; 31: 299-301.
16. NAKAYAMA M, YASUE H, YOSHIMURA M et al.: T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-70.
17. MARKUS HS, RUIGROK Y, ALI N, POWELL JF: Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 1998; 29: 1908-11.
18. FATINI C, GENSINI F, STICCHI E et al.: High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. Am J Med 2002; 112: 540-4.
19. MARTIN J, PACO L, RUIZ W, LOPEZ-NEVOT MA et al.: Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Sch6nlein purpura in northwestern Spain. J Rheumatol 2005; 32: 1081-5.
20. GONZALEZ-GAY MA, LLORCA J, SANCHEZ E et al.: Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in Northwest Spain. Rheumatology (Oxford) 2004; 43: 1182-5.